Biocorrx (OTCMKTS:BICX) Shares Pass Below 50-Day Moving Average – Time to Sell?

Shares of Biocorrx Inc. (OTCMKTS:BICX) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.38 and traded as low as $0.2725. Biocorrx shares last traded at $0.2725, with a volume of 350 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Biocorrx to a “hold” rating in a research report on Tuesday, September 2nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Biocorrx Price Performance

The company has a market capitalization of $6.62 million, a price-to-earnings ratio of -0.85 and a beta of 0.17. The stock has a 50 day simple moving average of $0.38 and a two-hundred day simple moving average of $0.38.

Biocorrx (OTCMKTS:BICX) last posted its earnings results on Friday, November 14th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). The company had revenue of $0.63 million during the quarter, compared to analysts’ expectations of $0.19 million.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.